Cases of Adverse Drug Events in pediatrics: Prospective Study at a Hospital in Rabat (Morocco)

    Published on:July/2018
    Journal of Young Pharmacists, 2018; 10(3):362-366
    Case Report | doi:10.5530/jyp.2018.10.80

    Laila Torissi1,2,*, A. Soulaymani1, A. Mokhtari1, R.Soulaymani3

    1Laboratoire de Génétique et Biométrie, Faculté des Sciences, Université Ibn Tofail, Kénitra, MAROC.

    2Direction du Médicament et de la Pharmacie (DMP), Ministère de la Santé, Rabat, MAROC.

    3Antipoison Center and Pharmacovigilance of Morocco, Rabat, MOROCCO.


    Pharmacovigilance aims to guarantee the safe use of medicines. It is based on the reporting of adverse effects by health professionals, industry and the public. Pharmacovigilance is the monitoring of drugs and the prevention of the risk of adverse effects resulting from their use, whether this risk is potential or proven. It relies on the spontaneous reporting of adverse events by health professionals and patients, the collection of adverse effects for the detection of signals the establishment of preventive measures. Many studies have highlighted the importance of harm related to Adverse Drug Events especially in children. In connection with this, we carried out a study of the undesirable effects of medicines at the Children’s Hospital of Rabat. This study was authorized by the Ministry of Health and lasted 6 months during which were recollected several cases including 10 cases presented in this article.

    Key words: Newborns, Children, Adverse drug reactions, Pharmacovigilance, Prospective study.

    Article Download